-
1
-
-
0031812042
-
A systematic review and meta-analysis of family history and risk of ovarian cancer
-
Stratton JF, Pharoah PDP, Smith SK, Easton DF, Ponder BAJ. A systematic review and meta-analysis of family history and risk of ovarian cancer. Br J Obstet Gynecol 1998;105:493-9
-
(1998)
Br J Obstet Gynecol
, vol.105
, pp. 493-499
-
-
Stratton, J.F.1
Pharoah, P.D.P.2
Smith, S.K.3
Easton, D.F.4
Ponder, B.A.J.5
-
2
-
-
0028113345
-
A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1
-
Miki Y, Swensen J, Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994;266:66-71.
-
(1994)
Science
, vol.266
, pp. 66-71
-
-
Miki, Y.1
Swensen, J.2
Shattuck-Eidens, D.3
-
3
-
-
0006713602
-
Identification of the breast cancer susceptibility gene BRCA2
-
Wooster R, Bignell G, Lancaster J, et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 1995;378:789-92.
-
(1995)
Nature
, vol.378
, pp. 789-792
-
-
Wooster, R.1
Bignell, G.2
Lancaster, J.3
-
4
-
-
17344365851
-
Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium
-
Ford D, Easton DF, Stratton M, et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 1998; 62:676-89.
-
(1998)
Am J Hum Genet
, vol.62
, pp. 676-689
-
-
Ford, D.1
Easton, D.F.2
Stratton, M.3
-
5
-
-
0033365227
-
The contribution of germline BRCA1 and BRCA2 mutations to familial ovarian cancer: No evidence for other ovarian cancer-susceptibility genes
-
Gayther SA, Russell P, Harrington P, Antoniou AC, Easton DF, Ponder BA. The contribution of germline BRCA1 and BRCA2 mutations to familial ovarian cancer: no evidence for other ovarian cancer-susceptibility genes. Am J Hum Genet 1999;65:1021 -9.
-
(1999)
Am J Hum Genet
, vol.65
, pp. 1021-1029
-
-
Gayther, S.A.1
Russell, P.2
Harrington, P.3
Antoniou, A.C.4
Easton, D.F.5
Ponder, B.A.6
-
6
-
-
37049023252
-
Contribution of BRCA1 and BRCA2 mutations to inherited ovarian cancer
-
Ramus SJ, Harrington PA, Pye C, et al. Contribution of BRCA1 and BRCA2 mutations to inherited ovarian cancer. Hum Mutat 2007;28:1207-15.
-
(2007)
Hum Mutat
, vol.28
, pp. 1207-1215
-
-
Ramus, S.J.1
Harrington, P.A.2
Pye, C.3
-
7
-
-
0037033733
-
A comprehensive model for familial breast cancer incorporating BRCA1 BRCA2 and other genes
-
Antoniou AC, Pharoah PD, McMullan G, et al. A comprehensive model for familial breast cancer incorporating BRCA1 BRCA2 and other genes. Br J Cancer 2002;86:76-83.
-
(2002)
Br J Cancer
, vol.86
, pp. 76-83
-
-
Antoniou, A.C.1
Pharoah, P.D.2
McMullan, G.3
-
8
-
-
0031003498
-
Contribution of BRCA1 mutations to ovarian cancer
-
Stratton JF, Gayther SA, Russell P, et al. Contribution of BRCA1 mutations to ovarian cancer. N Engl J Med 1997;336:1125-30.
-
(1997)
N Engl J Med
, vol.336
, pp. 1125-1130
-
-
Stratton, J.F.1
Gayther, S.A.2
Russell, P.3
-
9
-
-
0031958466
-
BRCA1 BRCA2, and hereditary nonpolyposis colorectal cancer gene mutations in an unselected ovarian cancer population: Relationship to family history and implications for genetic testing
-
Rubin SC, Blackwood MA, Bandera C, et al. BRCA1 BRCA2, and hereditary nonpolyposis colorectal cancer gene mutations in an unselected ovarian cancer population: relationship to family history and implications for genetic testing. Am J Obstet Gynecol 1998; 178:670-7.
-
(1998)
Am J Obstet Gynecol
, vol.178
, pp. 670-677
-
-
Rubin, S.C.1
Blackwood, M.A.2
Bandera, C.3
-
10
-
-
0032945329
-
Germ-line BRCA1 alterations in a population-based series of ovarian cancer cases
-
Janezic SA, Ziogas A, Krumroy LM, et al. Germ-line BRCA1 alterations in a population-based series of ovarian cancer cases. Hum Mol Genet 1999;8: 889-97.
-
(1999)
Hum Mol Genet
, vol.8
, pp. 889-897
-
-
Janezic, S.A.1
Ziogas, A.2
Krumroy, L.M.3
-
11
-
-
0035098503
-
Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer
-
Risen HA, McLaughlin JR, Cole DE, et al. Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. Am J Hum Genet 2001;68:700-10.
-
(2001)
Am J Hum Genet
, vol.68
, pp. 700-710
-
-
Risen, H.A.1
McLaughlin, J.R.2
Cole, D.E.3
-
12
-
-
29144509766
-
BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases
-
Pal T, Permuth-Wey J, Betts JA, et al. BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases. Cancer 2005;104:2807 -16.
-
(2005)
Cancer
, vol.104
, pp. 2807-2816
-
-
Pal, T.1
Permuth-Wey, J.2
Betts, J.A.3
-
13
-
-
33845654907
-
Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: A kin-cohort study in Ontario, Canada
-
Risch HA, McLaughlin JR, Cole DE, et al. Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada. J Natl Cancer Inst 2006;98:1694 - 706.
-
(2006)
J Natl Cancer Inst
, vol.98
, pp. 1694-1706
-
-
Risch, H.A.1
McLaughlin, J.R.2
Cole, D.E.3
-
14
-
-
0034948376
-
BRCA1 and BRCA1 mutations among 233 unselected Finnish ovarian carcinoma patients
-
Sarantaus L,Vahteristo P, Bloom E, et al. BRCA1 and BRCA1 mutations among 233 unselected Finnish ovarian carcinoma patients. Eur J Hum Genet 2001;9: 424-30.
-
(2001)
Eur J Hum Genet
, vol.9
, pp. 424-430
-
-
Sarantaus, L.1
Vahteristo, P.2
Bloom, E.3
-
15
-
-
9444248601
-
High prevalence of the 999del5 mutation in Icelandic breast and ovarian cancer patients
-
Johannesdottir G, Gudmundsson J, Bergthorsson JT, et al. High prevalence of the 999del5 mutation in Icelandic breast and ovarian cancer patients. Cancer Res1996;56:3663-5.
-
Cancer Res1996;56
, pp. 3663-3665
-
-
Johannesdottir, G.1
Gudmundsson, J.2
Bergthorsson, J.T.3
-
16
-
-
0033031573
-
Three percent of Norwegian ovarian cancers are caused by BRCA1 1675delA or 1135insA
-
Dorum A, Hovig E, Tropé C, Inganas M, Møiler P. Three percent of Norwegian ovarian cancers are caused by BRCA1 1675delA or 1135insA. Eur J Cancer 1999;35;779-81.
-
(1999)
Eur J Cancer
, vol.35
, pp. 779-781
-
-
Dorum, A.1
Hovig, E.2
Tropé, C.3
Inganas, M.4
Møiler, P.5
-
17
-
-
0034813329
-
A founder mutation of the BRCA1 gene in western Sweden associated with a high incidence of breast and ovarian cancer
-
Einbeigi Z, Bergman A, Kindblom LG, et al. A founder mutation of the BRCA1 gene in western Sweden associated with a high incidence of breast and ovarian cancer. Eur J Cancer 2001;37:1904-9.
-
(2001)
Eur J Cancer
, vol.37
, pp. 1904-1909
-
-
Einbeigi, Z.1
Bergman, A.2
Kindblom, L.G.3
-
18
-
-
1642554820
-
One in 10 ovarian cancer patients carry germ line BRCA1 or BRCA2 mutations: Results of a prospective study in southern Sweden
-
Malander S, Ridderheim M, Masback A, et al. One in 10 ovarian cancer patients carry germ line BRCA1 or BRCA2 mutations: results of a prospective study in southern Sweden. Eur J Cancer 2004;40:422-8.
-
(2004)
Eur J Cancer
, vol.40
, pp. 422-428
-
-
Malander, S.1
Ridderheim, M.2
Masback, A.3
-
19
-
-
33645648785
-
M, Kruger Kjaer S, Gayther SA Ovarian cancer and genetic susceptibility in relation to the BRCA1 and BRCA2 genes. Occurrence, clinical importance and intervention
-
Søgaard M, Kruger Kjaer S, Gayther SA Ovarian cancer and genetic susceptibility in relation to the BRCA1 and BRCA2 genes. Occurrence, clinical importance and intervention. Acta Obstet Gynecol Scand 2006;85:93-105.
-
(2006)
Acta Obstet Gynecol Scand
, vol.85
, pp. 93-105
-
-
Søgaard1
-
20
-
-
0034990616
-
BRCA1 and BRCA2 mutation status and cancer family history of Danish women affected with multifocal or bilateral breast cancer at a young age
-
Bergthorsson JT, Ejlertsen B, Olsen JH, et al. BRCA1 and BRCA2 mutation status and cancer family history of Danish women affected with multifocal or bilateral breast cancer at a young age. J Med Genet 2001;38:361-8.
-
(2001)
J Med Genet
, vol.38
, pp. 361-368
-
-
Bergthorsson, J.T.1
Ejlertsen, B.2
Olsen, J.H.3
-
21
-
-
0031035045
-
A 1-kb Alu-mediated germ-line deletion removing BRCA1 exon 17
-
Puget N,Torchard D, Serova-Sinilnikova OM, et al. A 1-kb Alu-mediated germ-line deletion removing BRCA1 exon 17. Cancer Res 1997;57:828-31.
-
(1997)
Cancer Res
, vol.57
, pp. 828-831
-
-
Puget, N.1
Torchard, D.2
Serova-Sinilnikova, O.M.3
-
22
-
-
16944363592
-
BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients
-
Petrij-Bosch A, PeelenT, van Vliet M, et al. BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients. Nat Genet 1997;17: 341 -5.
-
(1997)
Nat Genet
, vol.17
, pp. 341-345
-
-
Petrij-Bosch, A.1
PeelenT2
van Vliet, M.3
-
23
-
-
18744401644
-
Genomic rearrangements in the BRCA1 and BRCA2 genes
-
Mazoyer S. Genomic rearrangements in the BRCA1 and BRCA2 genes. Hum Mutat 2005;25:415-22.
-
(2005)
Hum Mutat
, vol.25
, pp. 415-422
-
-
Mazoyer, S.1
-
24
-
-
33745726046
-
Low frequency of large genomic rearrangements of BRCA1 and BRCA2 in western Denmark
-
Thomassen M, Gerdes AM, Cruger D, Jensen PKA, Kruse TA. Low frequency of large genomic rearrangements of BRCA1 and BRCA2 in western Denmark. Cancer Genet Cytogenet 2006;168:168-71.
-
(2006)
Cancer Genet Cytogenet
, vol.168
, pp. 168-171
-
-
Thomassen, M.1
Gerdes, A.M.2
Cruger, D.3
Jensen, P.K.A.4
Kruse, T.A.5
-
25
-
-
11144354423
-
Pathology of ovarian cancers in BRCA1 and BRCA2 carriers
-
Lakhani SR. Manek S, Penault-Llorca F, et al. Pathology of ovarian cancers in BRCA1 and BRCA2 carriers. Clin Cancer Res 2004;10:2473-81.
-
(2004)
Clin Cancer Res
, vol.10
, pp. 2473-2481
-
-
Lakhani, S.R.1
Manek, S.2
Penault-Llorca, F.3
-
26
-
-
10544220023
-
Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1
-
Rubin SC, Benjamin I, Behbakht K, et al. Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1 N Engl J Med 1996; 335:1413-6.
-
(1996)
N Engl J Med
, vol.335
, pp. 1413-1416
-
-
Rubin, S.C.1
Benjamin, I.2
Behbakht, K.3
-
27
-
-
0034600109
-
Clinicopatho-logic features of BRCA-linked and sporadic ovarian cancer
-
Boyd J, Sonoda Y, Federici MG, et al. Clinicopatho-logic features of BRCA-linked and sporadic ovarian cancer. JAMA 2000;283:2260-5.
-
(2000)
JAMA
, vol.283
, pp. 2260-2265
-
-
Boyd, J.1
Sonoda, Y.2
Federici, M.G.3
-
28
-
-
17444448154
-
Survival of BRCA1 breast and ovarian cancer patients: A population-based study from southern Sweden
-
Johannsson OT, Ranstam J, Borg A, Olsson H. Survival of BRCA1 breast and ovarian cancer patients: a population-based study from southern Sweden. J Clin Oncol 1998;16:398-404.
-
(1998)
J Clin Oncol
, vol.16
, pp. 398-404
-
-
Johannsson, O.T.1
Ranstam, J.2
Borg, A.3
Olsson, H.4
-
29
-
-
0033558282
-
Survival in familial, BRCA1 and BRCA2 associated epithelial ovarian cancer
-
Pharoah PDP, Easton DF, Stockton DL, Gayther SA, Ponder BAJ. Survival in familial, BRCA1 and BRCA2 associated epithelial ovarian cancer. Cancer Res 1999;59:868-71.
-
(1999)
Cancer Res
, vol.59
, pp. 868-871
-
-
Pharoah, P.D.P.1
Easton, D.F.2
Stockton, D.L.3
Gayther, S.A.4
Ponder, B.A.J.5
-
30
-
-
7544222400
-
Hormone therapy and the impact of estrogen intake on the risk of ovarian cancer
-
Glud E, Kjaer SK, Thomsen BL, et al. Hormone therapy and the impact of estrogen intake on the risk of ovarian cancer. Arch Intern Med 2004;164: 2253-9.
-
(2004)
Arch Intern Med
, vol.164
, pp. 2253-2259
-
-
Glud, E.1
Kjaer, S.K.2
Thomsen, B.L.3
-
31
-
-
0031612929
-
Nomenclature Working Group. Recommendations for a nomenclature system for human gene mutations. Nomenclature Working Group
-
Antonarakis SE; Nomenclature Working Group. Recommendations for a nomenclature system for human gene mutations. Nomenclature Working Group. Hum Mutat 1998;11:1-3.
-
(1998)
Hum Mutat
, vol.11
, pp. 1-3
-
-
Antonarakis, S.E.1
-
32
-
-
17944388284
-
Breast cancer information on the Web
-
Friend S, Borresen AL, Brody L, et al. Breast cancer information on the Web. Nat Genet 1995;11:238-9.
-
(1995)
Nat Genet
, vol.11
, pp. 238-239
-
-
Friend, S.1
Borresen, A.L.2
Brody, L.3
-
33
-
-
25144496606
-
PMUT: A Web-based tool for the annotation of pathological mutations on proteins
-
Ferrer-Costa C, Gelpí JL, Zamakola L, Parraga I, de la Cruz X, Orozco M. PMUT: a Web-based tool for the annotation of pathological mutations on proteins. Bioinformatics 2005;21:3176-8.
-
(2005)
Bioinformatics
, vol.21
, pp. 3176-3178
-
-
Ferrer-Costa, C.1
Gelpí, J.L.2
Zamakola, L.3
Parraga, I.4
de la Cruz, X.5
Orozco, M.6
-
34
-
-
33750353461
-
Predicting the effects of amino acid substitutions on protein function
-
Ng PC, Henikoff S. Predicting the effects of amino acid substitutions on protein function. Annu Rev Genomics Hum Genet 2006;7:61 -80.
-
(2006)
Annu Rev Genomics Hum Genet
, vol.7
, pp. 61-80
-
-
Ng, P.C.1
Henikoff, S.2
-
35
-
-
33644847172
-
Prediction of protein stability changes for single-site mutations using support vector machines
-
Cheng J, Randall A, Baldi P. Prediction of protein stability changes for single-site mutations using support vector machines. Proteins 2006;62: 1125-32.
-
(2006)
Proteins
, vol.62
, pp. 1125-1132
-
-
Cheng, J.1
Randall, A.2
Baldi, P.3
-
36
-
-
0033955496
-
Risk models for familial ovarian and breast cancer
-
Antoniou AC, Gayther SA, Stratton JF, Ponder BA, Easton DF. Risk models for familial ovarian and breast cancer. Genet Epidemiol 2000;18:173-90.
-
(2000)
Genet Epidemiol
, vol.18
, pp. 173-190
-
-
Antoniou, A.C.1
Gayther, S.A.2
Stratton, J.F.3
Ponder, B.A.4
Easton, D.F.5
-
37
-
-
0038744296
-
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: A combined analysis of 22 studies
-
Antoniou A, Pharoah PD, Narod S, et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 2003;72:1117-30.
-
(2003)
Am J Hum Genet
, vol.72
, pp. 1117-1130
-
-
Antoniou, A.1
Pharoah, P.D.2
Narod, S.3
|